Nanostructured Lipid Carrier (Nlc): A Cutting Edge Drug Delivery System
Nanostructured Lipid Carriers (NLCs) are an advanced form of drug delivery system, particularly designed for enhancing the oral bioavailability of lipophilic (fat-loving) medications. Traditional lipid matrices have been used to deliver such drugs more effectively by increasing their absorption in the body. NLCs, the third generation of these lipid-based carriers, are composed of a blend of solid and liquid lipids that do not mix well at a molecular level, known as spatially incompatible lipids. This unique composition of NLCs remains stable at room temperature and addresses several limitations found in earlier lipid carriers like solid lipid nanoparticles (SLNs). The inclusion of liquid lipids within the solid lipid matrix creates structural imperfections, which allow for higher drug loading and prevent the drug from being expelled during storage. This structure also facilitates a more controlled and sustained release of the drug, improving its overall efficacy. NLCs are versatile, meaning they can be used for various drug delivery methods, especially oral delivery. Their benefits include enhanced drug stability, improved solubility, and a higher capacity for drug loading. Additionally, NLCs are relatively easy to manufacture on a large scale, making them a practical option for pharmaceutical companies. This review offering a promising solution for the effective and scalable delivery of lipophilic drugs.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-10-02
- DOI
- https://doi.org/10.5281/zenodo.13882361
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00